Inroads to Anastomosis for Surgical Coronary Revascularization
This article was originally published in Start Up
Executive Summary
For emerging device companies, the course of success in coronary surgery markets never did run smooth, but progress in anastomosis devices has been particularly halting. That's not to say that start-ups can't make it here, though. Cardica is making inroads to the market, and Health Research International, in its recent report, "US Opportunities in Surgical Coronary Revascularization," which forecasts a 14% growth rate in the market over the next several years, identifies several young companies with promising devices in development.